As of January 1, 2016, after being a PhD student in the Biochem Dept between 1972 and 1975 and subsequently a member of the faculty for 37+ years (9/1978-12/2015) and a full Prof. since 1988, Ken Marcu has retired and is now an Emeritus Professor at Stony Brook University. Although Ken no longer has his own lab in the Biochem. Dept, in the positive spirit of being a truly socialistic, (eg., non capitalistic and not for profit, socialistic scientist, assuming that continuing to publish good science about our Earth and Nature is for everyone), Ken is continuing with all of his research projects: (1) At Stony Brook with Rich Kew in the Pathology Dept on our responses to damaged tissues (including reactions to sepsis) and also at Stony Brook. In his retirement Ken will only be living in Bologna, Italy and will be returning to the USA ~4 times each year in 7-12 day time spans to continue to give his block of 5-6 lectures on B Lymphocyte development and function in immunity each September in Prof. Howard Fleit’s graduate immunology course (HBP 533) in the Pathology Dept., which is an elective course for the MCB and Genetica and Microbiology Grad. Programs and to advise and work with his colleagues else in the USA at the Hospital for Special Surgery in Manhattan, NY (in collaboration with colleagues at the Rizzoli Orthopedic Research Institute in Bologna, Italy) on how the IKKs regulate chondrocyte hypertrophic differentiation and contribute in vivo to the onset and development of osteoarthritic disease and on other projects with his colleagues at San Diego State University he will continue to explore and decipher the mechanisms of NF-kappaB signaling in Flaviveridea virus infectious diseases and in other projects with his colleagues at the BRFAA institute in Athens,Greece on how the IKKs contribute to lung onset and development and how our innate immune system via our dendritic and macrophage sentinel cells responds to viral infections by activating the IKK>NFkappaB signaling pathways.